ADHD: why a careful evaluation matters

Attention problems rarely have a single cause

The overlap is larger than most people realize. Adults with ADHD have markedly higher rates of anxiety, depression, bipolar disorder, substance-use disorders and sleep disorders than other adults. And sleep deprivation on its own can produce inattention and executive-function problems that are essentially indistinguishable from ADHD in an interview. So 'I can't focus' has a long list of possible drivers — and often more than one is involved at once.

Why an accurate diagnosis reaches back to childhood

Diagnostic criteria (DSM-5-TR) require several symptoms before age 12, symptoms in two or more settings, and clear interference with work, school or relationships. For an adult who was never diagnosed as a child, establishing that takes a careful developmental history. Self-report checklists like the ASRS are useful screens, but a positive screen cannot establish the diagnosis. That's why guidelines recommend gathering records, school history, or input from people who have known you a long time: it protects the accuracy of the diagnosis.

What a careful ADHD evaluation looks at

A thorough evaluation weighs onset and developmental history; evidence of real impairment across more than one area of life; and the conditions that imitate or accompany ADHD — sleep disorders, mood and anxiety disorders, trauma, substance-use risk, medical contributors, and medication effects. Records are reviewed when relevant, and when the picture stays unclear, neuropsychological testing can add objective measures. The point is to separate ADHD from its mimics, and to find them when they coexist.

Stimulants work — which is exactly why the diagnosis has to be right

Stimulants are first-line and outperform placebo in controlled trials; individual response varies. That effectiveness is the reason precision matters. Stimulants are also Schedule II controlled substances, and prescription-stimulant misuse is common in the U.S. Safe-prescribing practice includes checking the state prescription-monitoring database (PDMP), a treatment agreement, regular follow-up with heart-rate and blood-pressure checks, and often extended-release formulations, which are harder to misuse.

There are non-stimulant options too

For people who prefer to avoid stimulants, have a history of substance misuse, or don't tolerate them, options include atomoxetine and viloxazine (FDA-approved for adults) and, off-label, bupropion. These have little misuse potential, but they can also raise heart rate and blood pressure, so cardiac history is reviewed for every option. A good plan fits the medication to the whole person.

The goal is the right answer, not a label

The purpose of a careful evaluation is not to force one diagnosis or to withhold treatment. It is to understand what is actually driving the attention and functioning problems — and then to choose a safe, effective next step, whether that's stimulant medication with proper monitoring, a non-stimulant, treating an underlying sleep or mood problem, or some combination. An accurate answer is what makes treatment work.

Related service